Table 1.
Control | HFFD | 0.008% LCBs | 0.025% LCBs | |
---|---|---|---|---|
Body weight gain (g) | 15.5 ± 1.7 | 28.6 ± 2.1## | 24.0 ± 2.3 | 18.6 ± 1.1** |
Epididymal adipose weight (g) | 0.554 ± 0.083 | 1.67 ± 0.20## | 1.35 ± 0.22 | 0.868 ± 0.127** |
Serum TNF-α (pg/mL) | 287 ± 13 | 536 ± 30## | 479 ± 25* | 304 ± 19** |
Serum CRP (ng/mL) | 92.3 ± 6.6 | 137 ± 18## | 124 ± 10 | 102 ± 8* |
Serum MIP-1 (pg/mL) | 28.9 ± 1.4 | 56.3 ± 3.4## | 50.4 ± 2.1 | 36.6 ± 2.4** |
Serum IL-1β (pg/mL) | 54.3 ± 6.1 | 71.8 ± 4.4## | 67.5 ± 3.7 | 62.2 ± 4.1* |
Serum IL-6 (pg/mL) | 32.9 ± 3.7 | 52.5 ± 4.4## | 47.7 ± 3.6 | 41.1 ± 2.4** |
Serum IL-10 (pg/mL) | 122 ± 7 | 70.1 ± 5.7## | 102 ± 7* | 91.8 ± 8.5** |
Serum ROS (U/mL) | 164 ± 8 | 258 ± 13## | 233 ± 11 | 189 ± 6** |
Serum FFAs (μmol/L) | 236 ± 14 | 376 ± 20## | 315 ± 12* | 270 ± 10** |
Hepatic ROS (U/mg) | 48.0 ± 3.1 | 97.2 ± 6.7## | 83.8 ± 6.2 | 60.4 ± 5.3** |
Hepatic FFAs (μmol/mg) | 0.449 ± 0.016 | 1.38 ± 0.09## | 1.16 ± 0.11 | 0.735 ± 0.039** |
The obesity model mice were established by fed HFFD. Data are presented as mean ± standard deviation (n = 12/group). Multiple comparisons were done using one way ANOVA.
p < 0.01 versus control;
p < 0.05,
p < 0.01 versus HFFD.
CRP = C-reactive protein; FFA = free fatty acid; HFFD = high-fat fructose diet; IL = interleukin; LCBs = long-chain bases; MIP = macrophage inflammatory protein; ROS = reactive oxygen species; TNF = tumor necrosis factor-α.